Myriad Genetics. has filed a patent for a method and system to analyze sex-chromosome aneuploidies in individuals. The method involves training a neural network model and using a machine learning algorithm to determine the sex-chromosome status based on normalized read depth for a gene in the individual’s genome. GlobalData’s report on Myriad Genetics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Myriad Genetics, Personalized medicine biomarkers was a key innovation area identified from patents. Myriad Genetics's grant share as of January 2024 was 28%. Grant share is based on the ratio of number of grants to total number of patents.
Method for analyzing sex-chromosome aneuploidies using neural network
A patent application (Publication Number: US20240038339A1) describes a method and system for analyzing sex-chromosome aneuploidies in individuals using a neural network model and machine learning algorithms. The method involves training the neural network model based on predetermined information related to sex chromosomes and determining the sex-chromosome status based on normalized read depth for a gene in the individual's genome. The system includes a neural network model that can provide a twin sex call and determine complex sex phenotypes like vanishing twins and mosaic monosomy. Additionally, the method and system can provide a negative result when the sex-chromosome status is anomalous and determine the status via Bayesian statistics, graphing, or visualization of read depth and allosome data.
The system further includes features such as determining a probability of sex-chromosome status for multiple samples, heuristic data analysis, and expert human review as a truth set. The neural network model can be optimized through automated retraining protocols to synchronize training over time, reduce drift, and validate performance. Confidence levels for the respective sex-chromosome status can also be determined. Overall, the method and system offer a comprehensive approach to analyzing sex-chromosome aneuploidies in individuals, incorporating advanced technologies like neural networks and machine learning algorithms to provide accurate and detailed results for various sex-chromosome statuses and phenotypes.
To know more about GlobalData’s detailed insights on Myriad Genetics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
